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ABSTRACT
Introduction: Defensins are small anti-microbial peptides produced by epithelial cells. These peptides 
have a broad range of actions against microorganisms, including Gram-positive and Gram-negative bac-
teria. Human defensins are classifi ed into two subfamilies, the α-, and β- defensins, which differ in their 
distribution of disulphide bonds between the six conserved cysteine residues. Defensins are found in saliva 
and others compartments of the body. Human β defensins 2 (hBD2), beta defensins 4 (hBD4) and alpha 
defensins 4 (hNP4) in saliva may contributes to vulnerability or resistance to caries. This study aimed to de-
termine a possible correlation between caries and levels of defensins measuring the expression in gingival 
tissue and concentrations in saliva samples.
Methods: Oral examinations were performed on 100 adults of both genders (18-30 years old), and un-
stimulated whole saliva was collected for immunoassays of the three peptides and for the salivary pH, buf-
fer capacity, protein, and peroxidase activity. mRNA levels of defensins in gingival sample were assessed 
by semi-quantitative RT-PCR technique. 
Results: The median salivary levels of hBD2 and hBD4 were 1.88 μg/ml and 0.86 μg/ml respectively for 
the caries-free group (n=44) and 7.26 μ/ml (hBD2) and 4.25 μg/ml (hBD4) for all subjects with evidence 
of caries (n=56). There was no difference in the levels of hNP4, salivary pH, and proteins between groups, 
however the peroxidase activity and buffer capacity (interval 6.0-5.0) were reduced in caries group. Tran-
scriptional levels of hBD2 and hBD4 did correlate with caries experience, the mRNA expression of hBD2 
and hBD4 were signifi cantly higher in patients with caries than in patients with no-caries (p < 0.01). 
Conclusion: We conclude that high salivary levels and expression of beta defensins, low peroxidase activ-
ity and buffer capacity may represent a biological response of oral tissue to caries. Our observation could 
lead to new ways to prevent caries and a new tool for caries risk assessment.
Keywords: Saliva, Antimicrobial Peptides, Defensins, Caries.
Increased expression and levels of human β defen-
sins (hBD2 and hBD4) in adults with dental caries
Girolamo Jose Barrera1,2*, Gabriela Sanchez Tortolero1, Adriana Rivas1,
Carmen Flores1, Jose Emanuele Gonzales1
1Laboratorio de Biotecnologia Aplicada L.B.A., Av. Don Julio Centeno, San Diego, Venezuela. 2Universidad de Carabobo, 
Departamento Clínico-Integral, Escuela de Bioanálisis, Maracay, Venezuela.
INTRODUCTION
Saliva plays a central role in oral health (1,2). Saliva 
is produced and secreted from salivary glands. Th e 
basic secretory units of salivary glands are clusters 
of cells called acini. Th ese cells secrete a fl uid that 
contains water, electrolytes, mucus, enzymes and 
*Corresponding author: Barrera Girolamo Jose; 
Laboratorio de Biotecnologia Aplicada L.B.A., Av. Don 
Julio Centeno, San Diego, Venezuela. Apartado 2001
Tel: +58-412-5071616; Fax: +58-241-872-6525
E-mail address: girolamobarrera@hotmail.com
Submitted 3 July 2013 / Accepted 10 September 2013
  RESEARCH ARTICLE                   Open Access
89
http://www.jhsci.ba  Girolamo Jose Barrera et al. Journal of Health Sciences 2013;3(2):88-97
antimicrobial peptides, all of which fl ow out of the 
acinus into collecting ducts. Antimicrobial peptides 
are important members of the host defense system. 
Th ey have a broad ability to kill microbes (3). In 
human the two main antimicrobial peptide families 
are defensins and cathelicidins. Defensins are small 
anti-microbial peptides act by disrupting the struc-
ture or function of microbial cell membranes, and 
are found in saliva and others compartments of the 
body (3). Evidence is accumulating that defensins 
play an important role in defense against pathogens 
and they are considered as part of innate immune 
response (3). Th ey have generally been considered 
to contribute to mucosal health; however, it is pos-
sible that these peptides can be considered biologi-
cal factors that infl uence the appearance of caries. 
Defensins are cysteine-rich, cationic peptides with 
β-pleated sheet structures. Mammalian defensins 
are classifi ed into three subfamilies, the α-, β- and 
θ-defensins, which diff er in their distribution of and 
disulphide bonds between the six conserved cysteine 
residues (4). Defensins have activity against a wide 
variety of bacteria, fungal, and viral targets. Under 
optimal conditions, antimicrobial activity of defen-
sins is observed at concentrations as low as 1-10 μg/
mL. Th e major mechanism of antimicrobial activity 
of all defensins is thought to occur through interac-
tion with the membrane of the invading microbe 
resulting in a release of the cell contents (5). Model 
bacteria (Escherichia coli ML-35) that were treated 
by defensins became permeable to small molecules. 
In bacteria, permeabilization coincided with the in-
hibition of RNA, DNA and protein synthesis and 
decreased bacterial viability as assessed by the colony 
forming assay. Conditions that interfered with per-
meabilization also prevented the loss of bacterial vi-
ability, indicating that permeabilization is essential 
for bacterial killing (6).
Th e human β defensins are widely expressed in oral 
tissues including gingival epithelium, salivary glands, 
ducts and saliva (3,4). It is known that these pep-
tides are involved in defense against bacteria that can 
colonize the oral mucosa. Th e presence of defensins 
in saliva implies their potential role in protecting 
tooth structure from bacterially-induced caries. Th e 
hBDs have broad antimicrobial activity against oral 
microorganisms such as Streptococcus mutans, Por-
phyromonas gingivalis and Actinobacillus actinomy-
cetemcomitans (3,5). Th e amount of hBDs expressed 
in saliva varies between individuals. Th is has been 
previously demonstrated for α- and β -defensins, 
histatin, and proline-rich proteins (7,8). Th is study 
shows that the levels of these peptides in unstimu-
lated saliva vary greatly between individuals, even 
when diff erences in total salivary protein are consid-
ered. To date there are no reports of normal values 
of defensins in human saliva. It has been proposed 
that the variation in concentration of defensins in 
saliva could be attributed to the genetic factors. Th e 
genes for hBDs lie in a cluster on human chromo-
some 8. Several genes in this region can occur as 
multiple repeated copies (9). It is not well known 
if human with several copies of hBD2, for example, 
produce more defensins than other peoples. In the 
same way, individual diff erences in the quantity of 
α- and β -defensins may be genetically determined. 
Th ere is also data for genetically determined factors 
in susceptibility to caries. Some evidence suggests 
individual diff erences in caries experience in pa-
tients within the same family (9). Th ese individual 
diff erences suggest that genetic factors may play an 
important role in caries resistance or susceptibility. 
Th e purpose of this study was to determine a pos-
sible correlation between hBDs levels in saliva and 
caries experience in adults. We show high levels and 
high expression of hBDs in adults with caries experi-
ence. Our fi ndings suggest that high salivary levels of 
hBD2 and hBD4 may contribute to caries response.
METHODS
Patients
Th is study was approved by the Institutional Review 
Board of the Applied Biotechnology Laboratory. 
Written informed consent was obtained from each 
participants. One hundred subjects participated in 
the study. Oral examinations were performed by 
trained calibrated clinicians using standardized pro-
cedures. All samples were obtained with informed 
consent. Examiners were instructed to rank subjects 
separately for active caries as follows: 0, caries-free 
group; 1, mild (one to three caries); 2, moderate 
(four to six caries); 3, severe (more than six car-
ies). All patients were apparently healthy and were 
excluded from the study patients with a history of 
systemic disease or taking medications likely to in-
fl uence periodontal health. 
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Collection of gingival samples
Tissue samples from caries group (n=4) were taken 
from interproximal sites showing redness and/or 
bleeding on probing, but no clinical attachment 
loss. Th e control specimens (caries-free group) (n=4) 
were collected during impacted third molar extrac-
tion surgery. All tissue samples were placed in Trizol 
solution and stored at -80ºC until the analysis.
Collection of saliva
Saliva samples were collected (4 to 6 ml) in a tube 
containing Nonidet P-40 to a fi nal concentration of 
0.2% v/v. Saliva was cleared by centrifugation twice 
at 3000 x g for 20 min at 4°C. Total protein concen-
tration was evaluated in the supernatant by bradford 
assay (10). Cleared unfractionated saliva was used 
for pH and buff er capacity determinations. Aliquots 
(200 μl) of supernatant were acid extracted by the 
addition of an equal volume of 1 M HCl/1% tri-
fl uoroacetic acid overnight at 4ºC (11). Th e sample 
was centrifuged, and the supernatant was concen-
trated by vacuum evaporation and resuspended in 
distilled water equal to the starting sample volume 
(11). Acid-extracted saliva was used for immunoas-
say (ELISA). 
pH and buffer capacity determinations
Cleared unfractionated saliva was used for pH de-
termination with a portable pH-meter (Cole Parmer 
ACCUMET AB15). Th e buff er capacity was deter-
mined by titration using 1 mL of saliva, with 0.01 
M HCl and after each addition of acid the change 
in pH was monitored up to pH 5.0. Th e buff er ca-
pacity was analyzed by ranges of pH. Th e volume 
of acid added to the saliva was calculated for each 
interval considered: initial pH-7.0, pH 7.0-6.0, and 
pH 6.0-5.0. Th e buff er capacity was expressed in 
volume (mL) of the acid added to 1 mL of saliva 
in the pH range considered, instead of equivalents 
of H. 
Activity of peroxidase
Peroxidase activity was measured in the patients’ 
saliva according to the 2-nitrobenzoic acid-thiocya-
nate (NBS-SCN) assay as previously described (12). 
Briefl y, the calorimetric change induced by the reac-
tion between the enzyme and the substrate, Dithio-
bis 2-Nitrobensoic Acid (DTNB) in the presence of 
mercapto-ethanol, was read at a wavelength of 412 
nm for 20 s. One unit of enzyme activity was de-
fi ned as the level of enzyme activity needed to cleave 
1 μmol of NBS/min at 22°C, using a molar extinc-
tion coeffi  cient of 12,800. 
ELISA
We coated 96-well immunoplates (MaxiSorp™; 
Nunc) with 100 μL of Acid-extracted saliva diluted 
in 0.05 mol/L carbonate buff er, pH 9.6, 4 °C, for 
12 h. Subsequently, we blocked the wells with 200 
μL of 1% bovine serum albumin (BSA) in PBS at 
room temperature for 2 h. After washing 5 times 
with 200 μL PBS containing 1 mL/L Tween 20, we 
incubated 100 μL/well with PBS containing 1% 
BSA and a 1:1000 dilution of anti-human BD2, 
BD4 or HNP4 (Santa Cruz Biotechnology) at room 
temperature for 2 h. Th e plates were washed 5 times 
with PBS containing 1 mL/L Tween 20, and wells 
were incubated at room temperature with 100 μL 
of peroxidase-coupled secondary antibody (Santa 
Cruz Biotechnology, cat. No. sc-2350 (for BD2 and 
HNP4) or cat. No. sc-2370 (for BD4) diluted to 
1:5000 in PBS plus 1 mL/L Tween 20 for 30 min. 
Plates were washed 5 times as described above, and 
incubated with 100 μL of substrate (0.2M Na2H-
PO4, 0.1M citric acid, 0.1% H2O2, 15mg O-phen-
ylenediamine dihydrochloride) to each well in the 
dark at room temperature for 10 min. Stop solution 
(100 μl, 0.5M H2SO4) was added to each well. Ab-
sorbance was measured at 405nm using a microti-
ter plate spectrophotometer Synergy HT (BioTek 
Instruments, Winooski, VT, USA).We quantifi ed 
hBDs by simultaneous ELISA runs using recombi-
nant hBDs as calibrators.
Reverse transcription polymerase 
chain reaction (RT-PCR)
Total RNA was extracted from all tissue samples by 
TrizolTM (Invitrogen) as previously descried (12, 13). 
RNA concentration and purity were measured using 
a spectrophotometer Synergy HT (BioTek Instru-
ments, Winooski, VT, USA). Total RNA (1 μg) was 
reverse transcribed into cDNA using a commercial 
kit (Invitrogen Th ermoScriptTM RT-PCR System), 
according to the manufacturer’s instructions. Con-
trol reactions to check for DNA contamination were 
run in parallel with samples processed without re-
verse transcriptase. PCR was performed in a fi nal vol-
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ume of 25 μl containing 1 μl of the reverse transcrip-
tion reaction, 50 μM deoxynucleotide triphosphates, 
1.5mM MgCl2, 50mM Tris–HCl (pH 8.0), 1 IU 
Taq DNA polymerase and 0.2 μM each of sense and 
antisense hBD2 and hBD4 primers (see sequences 
below). PCR was performed in an Eppendorf Mas-
tercycler STM thermocycler for 35 cycles consisting 
of denaturation at 94oC (1min), annealing at 60oC 
(1min) and extension at 72oC (1min). Amplifi cation 
was terminated by a fi nal extension step at 72oC for 
5min. A negative control without the cDNA tem-
plate was run with every assay to evaluate the overall 
specifi city. Th e integrity of the template RNA was 
checked by confi rming expression of β-actin mRNA. 
Th e primer sequences were: β-actin sense, CAC-
GCCATCCTGCGTCGGAC; β-actin antisense, 
CATGCCATCCTGCGTCTGGAC; hBD2 sense, 
TTCCTGATGCCTCTTCCA; and hBD2 anti-
sense, ATGTCGCACGTCTCTGA; hBD4 sense, 
GGCAGTCCCATAACCACATATTC; and hBD4 
antisense, TGCTGCTATTAGCCGTTTCTCTT, 
hNP4 sense, TGCCGGCGAACAGAACTTC-
GT; and hNP4 antisense, ACCGATGATGGC-
GTTCCCAGC, Aliquots (10 μl) of the polymerase 
chain reaction products were electrophoresed on 
1.5% agarose gels and stained with SYBR Gold 
nucleic acid gel stain (Molecular Probes, Invitro-
genTM). Densitometric analyses were performed us-
ing the image analysis software Quantity One (Bio-
Rad laboratories, Hercules, CA, USA). Briefl y, the 
digital image was analyzed to determine the pixel 
intensity of each band. Relative quantities of hBD2 
and hBD4 mRNA among diff erent preparations 
were calculated as the ratio of the hBD2: β-actin 
and hBD4: β-actin pixel intensities from three in-
dependent RT-PCR experiments. Positive results 




Fifty-four females and 46 males participated in the 
study. All subjects were between 18 and 32 years of 
age. Overall, the adults were healthy, with 90% hav-
ing no history of disease. Oral examination showed 
that 15% had loose teeth. Sixty-one percent of the 
population reported having regular dental care. Gin-
FIGURE 1.  pH, Buffer capacity and oral peroxidase activ-
ity in saliva. Cleared unfractionated saliva was used for pH 
determination. The buffer capacity was determined by titration 
using 1 mL of saliva, with 0.01 M HCl and after each addition 
of acid the change in pH was monitored up to pH 5.0. The 
buffer capacity was analyzed by ranges of pH. The volume 
of acid added to the saliva was calculated for each interval 
considered: initial pH-7.0, pH 7.0-6.0, and pH 6.0-5.0. No dif-
ference in the saliva pH between the groups was noted (A). 
Considering the pH intervals analyzed, the buffer capacity 
showed no difference between the groups either in the ini-
tial interval pH - 7.0 or pH 7.0-6.0. In the interval pH 6.0-5.0 
the caries-free group showed a higher value than the control 
group (P<0.05) (B). Peroxidase activity was measured as pre-
viously described (12). The caries-free group showed signifi -
cantly higher oral peroxidase activity than each of the groups 
with caries (*, P<0.05).
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FIGURE 2.  Defensins levels in saliva as a function of caries score. Saliva was thawed and cleared by centrifugation twice at 
3000 x g for 20 min at 4°C, proteins were precipitated with HCl-TCA. Defensins concentrations were determined by ELISA us-
ing anti-hBD2, anti-hBD4, or anti-hNP4 as primary antibody, as indicated in Materials and methods (12). The fi gure shows the 
measured concentrations of defensins expressed as μg/ml (A), and relative to salivary protein in μg/mg protein (B). hBD2, hBD4 
and hNP4 concentrations in saliva, expressed as μg/ml; (C, E and G) and relative to salivary protein in μg/mg protein (D, F and 
H). The caries group showed signifi cantly higher hBD2 and hBD4 concentration (A and B) than each of the groups with no caries 
(**, P<0.01). Each assay was carried out in three independent experiments, and results are reported as mean±S.D.
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givitis was noted in only a small number of subjects 
(10%). forty-four subjects (44%) had no dental car-
ies; 19 (19%), 25 (25%), and 12 (12%) had caries 
scores of 1, 2, and 3 or greater, respectively.
Salivary analysis
Th e median protein concentration of unstimulated 
saliva samples (n=44) were 1.35 mg/ml (range from 
0.63 to 2.67 mg/ml) for caries-free group and 1.29 
FIGURE 3.  Quantifi cation of differentially-expressed defensins mRNAs by RT-PCR. (A) Specifi c primers and annealing tem-
peratures employed. (B) RT-PCRs for hBD2, hBD4 and hNP4 were carried out from gingival samples divided in two main groups: 
caries-free (1-4) and caries (5-8). The PCR-products were run onto 2% agarose gel electrophoresis. Control reactions without 
reverse transcriptase were carried out. PCR was performed in a fi nal volume of 25μl containing 1μl of the reverse transcription 
reaction, 50μM of dNTPs, 1.5mM MgCl2, 50mM Tris–HCl (pH 8.0), 1 IU Taq polymerase and 0.2μM each of sense and antisense 
primers. Specifi c PCR for a constitutively expressed gene (β-actin) was carried out as a positive control (data no shown). The 
relative amount of product was quantifi ed by densitometric analysis of DNA bands (C). Defensins-mRNA expression levels are 
shownnormalized to β-actin. Results are mean ± SEM of three independent experiments.
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mg/mL (range from 0.79 to 2.89 mg/mL) for all 
subjects with evidence of caries (n=56). Th e salivary 
protein concentration showed no correlation with 
age, gender, or caries score (data not shown). No 
diff erence in the saliva pH between the groups was 
noted (Figure 1A). Considering the pH intervals 
analyzed, the buff er capacity showed no diff erence 
between the groups either in the initial interval pH 
- 7.0 or pH 7.0-6.0. In the interval pH 6.0-5.0 the 
caries-free group showed a higher value than the 
control group (P<0.05) (Figure 1B). Th e peroxidase 
activity was reduced for all subjects with evidence of 
caries when compared with the control group (P< 
0.05) (Figure 1C). Finally, the levels of salivary de-
fensins hBD2, hBD4 and hNP4 were in the μg/ml 
range (Figure 2A). hBD levels were also normalized 
to the protein concentration in whole saliva for each 
sample (Figure 2B).
Association between defensins 
and caries experience
In order to evaluate the relationship of defensins 
levels and caries experience in the population, we 
used the Kruskal-Wallis nonparametric test based 
on rank as previously reported (11,14). We found 
a signifi cant diff erence in the level of hBD2 and 
hBD4 among diff erent caries groups (P < 0.01). 
Diff erences were observed for both the median lev-
el of salivary defensins concentration (μg/ml) and 
salivary defensins relative to salivary protein (μg/
mg) (Figs. 2C-2F). On the other hand, there was 
not diff erence in the level of hNP4 among diff er-
ent group (Figs. 2G and 2H). Th e median salivary 
levels of hBD2, hBD4 and hNP4 were 7.26 μg/ml, 
4.25 μg/ml and 4.52 μg/ml respectively for the car-
ies group (n=44) and 1.88 μ/ml (hBD2), 0.86 μg/
ml (hBD4) and 3.91 μg/ml (hNP4) for all subjects 
with no evidence of caries (n=56). Th e defensins 
value relative to total salivary protein was 3.53 μg/
mg (hBD2), 2.07 μg/mg (hBD4) and 2.22 μg/mg 
(hNP4) protein in the caries group and 0.96 μg/
mg (hBD2), 0.44 μg/mg (hBD4) and 1.98 μg/mg 
(hNP4) protein in the caries-free group (P < 0.01). 
hBD2 and hBD4 concentration was positively cor-
related with caries score (r = 0.7525 and r = 0,7201 
respectively), and the correlation is signifi cant at the 
0.0001 level (P < 0.0001). No correlation was found 
between caries level and hNP4 concentration. Addi-
tionally, semi-quantitative RT-PCR was used to de-
termine whether the caries group present an increase 
in oral epithelial cell expression of hBD2 and hBD4 
mRNA. As shown in Figure 3, in the caries group 
there was a signifi cantly higher expression of hBD2 
and hBD4 compared with defensin levels in caries-
free group. On the other hand, there was no diff er-
ence in the expression of alpha defensin 4 (hNP4). 
Together, the results demonstrate that hBD2 and 
FIGURE 4.  Defensins values and caries in the population. 
The number of subjects with no caries (open bars) compared 
to those with caries (fi lled bars) with hBD2 (A), hBD4 (B) and 
hNP4 (C) concentrations (μg/ml saliva) in the ranges indicat-
ed. Note that an increasing proportion of subjects had caries 
as the defensins (hBD2 and hBD4) concentration increased. 
hNP4 analysis showed no signifi cant differences among the 
population, with the same levels of hNP4 in caries and caries 
free group.
95
http://www.jhsci.ba  Girolamo Jose Barrera et al. Journal of Health Sciences 2013;3(2):88-97
hBD4 were upregulated in caries group. To further 
examine the relationship of defensins with caries, 
the hBD2, hBD4 and hNP4 concentration range 
was evaluated in subjects with no caries compared 
to those with caries (Figure 4A-C). hBD2 analysis 
showed an increasing proportion of subjects had 
caries as the defensins concentration increased; 86% 
of the subjects with defensins levels lower than 3.0 
μg/ml (n = 48) had no caries, but only 15% of the 
subjects with hBD2 levels greater than 3.0 μg/ml (n 
= 8) had no caries (Figure 4A). Similar analysis for 
hBD4 is shown in Figure 4B. Th e results showed the 
same trend with higher levels of hBD4 in the caries 
group than in those with no caries. On the other 
hand, hNP4 analysis showed no signifi cant diff er-
ences among the population with the same levels of 
hNP4 in caries and caries free group (Figure 4C).
DISCUSSION 
Salivary constituents are potential candidates as bio-
logical factors infl uencing caries risk. Many salivary 
protein components, such as glycoprotein, immu-
noglobulins, agglutinin, lactoferrin, and defensins 
are thought to have a role in defense in the oral cav-
ity (15). Th e salivary protein concentration showed 
no correlation with age, gender, or caries score. Ac-
cording to Rudney et al. (16) a high protein concen-
tration in the saliva contributes to greater adherence 
of S. mutans, the fi rst resident of dental plaque, how-
ever, in this work there was no diff erence in pro-
tein levels between caries and no caries groups. Th e 
mean saliva pH values of the 2 groups were similar. 
In literature results are confl icting with respect to 
saliva pH. Factors such as collection methods (sites 
in the oral cavity), the ages, and diet can infl uence 
results (17). In the range of pH 7.0-6.0 the buff er 
capacity of saliva of the two groups was no diff er-
ent. In fact, the range pH 7.0-6.0 constitutes the 
most important pH interval related to dental cavity 
formation, since in this range two pKs of two buff er 
systems are found, namely, the bicarbonate/carbon-
ate system with a pK around 6.1 and the phosphate 
buff er system with a pK around 6.8. Th e presence 
of these two buff er systems in this range is the cause 
of the higher acid consumption in this pH interval. 
However, in the interval pH 6.0-5.0 the caries-free 
group showed a higher value than the control group 
(P<0.05). It is recommended to continue doing in-
vestigations in order to assess the levels of sodium bi-
carbonate in plasma because there are evidence that 
the bicarbonate is the most important buff er system 
of the saliva (18). In the same way, as Smith suggests 
(19), when the concentrations of bicarbonate of so-
dium in plasma are high, this excess can be excreted 
by the salivary glands, probably by the acinar cells. 
On the other hand, Lamanda (20) demonstrated 
that salivary buff ering between pH 3.4 and 5 was 
not based on hydrogencarbonate and dihydrogen-
phosphate but rather on proteins. However, further 
studies have to be undertaken to identify the protein 
buff er components in the human salivary proteome. 
Th e presence of the low capacity buff er in caries 
group evaluated could be related to high dental car-
ies risk, which might cause modifi cations in the ac-
id-base physiologic homeostasis, causing a decrease 
of the systemic buff er system and so, of the capac-
ity salivary buff er. Th e peroxidase activity is signifi -
cantly greater in caries-free adults than in those with 
caries. Oral Peroxidase (OPO) is composed of two 
peroxidase enzymes, salivary peroxidase (SPO) and 
myeloperoxidase (MPO). Th e SPO secreted from 
the major salivary glands, mainly the parotid gland 
(21), contributes 80% of OPO activity, while MPO, 
produced by leukocytes in infl ammatory regions of 
the oral cavity (22). Oral peroxidase is an enzyme 
with antimicrobial properties, and in the mouth, it 
is secreted by salivary glands and catalyzes the oxida-
tion of thiocyanate by hydrogen peroxide to produce 
on oxidized form of thiocyanate. Th e product of the 
reaction catalyzed by peroxidase inhibits bacterial 
growth (23). In this investigation, the decrease of 
peroxidase activity observed in caries group may be 
linked to the increase of dental caries risk. Numer-
ous studies have investigated the correlation among 
these salivary proteins and caries experience, but no 
studies have shown reliable association between a 
single salivary component and caries experience.
Th e expression of defensins in saliva and throughout 
the oral cavity suggests that they may have a central 
role in protecting tooth structure from dental car-
ies as well as protecting oral mucosa. Several reasons 
for this proposal are 1) Defensins have broad an-
timicrobial activity; 2) they stimulate the acquired 
immune system and could function to enhance 
IgA production as well as IgG production (24); 3) 
these defensins may function to keep overall bacte-
ria in check and to help prevent biofi lm formation. 
Th us, oral defensins may provide a natural antibi-
96
Girolamo Jose Barrera et al. Journal of Health Sciences 2013;3(2):88-97 http://www.jhsci.ba
otic barrier. Th ere are several new fi ndings of this 
study. First, hBD2, hBD4 and hNP4 are detectable 
in saliva but show extensive variation in concentra-
tion between subjects (Figure 2A-B). Th e concentra-
tion of defensins (BD2 and BD4) in unstimulated 
saliva of adults has not been previously reported, al-
though healthy adults had a mean value of 0.8 μg/
ml for other antimicrobial peptide such as human 
defensins-1(25). Second, salivary defensins (hBD2 
and hBD4) are signifi cantly greater in caries adults 
than in those with caries-free, however there are no 
diff erence in hNP4 levels between groups (Figure 
2G-H). Th ird, the defensins levels found in saliva 
in this study are in the range of eff ective antimi-
crobial function, especially considering the low salt 
concentration in saliva and the synergistic action of 
the peptides. Fourth, the correlation of a salivary 
cationic defensins with caries experience suggests 
the possible protective eff ect of hBD2 and hBD4. 
Conversely, low levels of defensins may result in in-
creased susceptibility to caries. In this work, salivary 
defensins concentrations showed large variation be-
tween individuals, with a signifi cantly higher level 
of salivary defensins in adults with caries. Finally, 
this study shows the simultaneous expression of 
human hBD2 and hBD4 in caries and caries free 
gingival tissue samples detected by semi-quantita-
tive RT-PCR. Previous studies demonstrated the 
constitutive expression of hBD2 in oral tissues (26). 
Our analysis of gene expression in caries and caries 
free group showed diff erential transcriptional levels 
for the defensins. In samples isolated from caries 
group, hBD2 and hBD4 expression was at a higher 
level than caries-free group. Th e lower expression 
of hBD2 and hBD4 in caries-free group could ex-
plain the lower concentration of these antimicrobial 
peptides in saliva. Th e salivary levels of hBD2 and 
hBD4 may represent a genetically determined fac-
tor that contributes to caries susceptibility. Th e large 
variation in the concentration of defensins in saliva 
could be due to previously demonstrated polymor-
phisms in sequence and copy number in the genes 
encoding these peptides (27).
Saliva is an easily available sample which can be col-
lected noninvasively and used to measure and moni-
tor the risk for caries (28). Th e oral cavity, which 
is colonized by numerous microorganisms, contains 
a wide selection of antibacterial peptides that play 
an important role in maintaining its complex eco-
logical homeostasis. We have shown that adults with 
caries have a signifi cantly higher expression and lev-
els of defensins (hBD2 and hBD4) based on both 
the RT-PCR and ELISA (Figure 2-3). Future stud-
ies could lead to development of means to enhance 
endogenous oral peptide expression, utilization of 
these peptides as therapeutics, and to a simple test 
for clinical evaluation of caries risk.
CONCLUSION
Salivary defensins are potential candidates as biolog-
ical factors infl uencing caries response. Th e higher 
expression of defensins in saliva suggests that they 
may have a central role in protecting tooth structure 
from dental caries as well as protecting oral mucosa 
We conclude that high salivary levels and expression 
of beta defensins may represent a biological response 
of oral tissue to caries. However, these suggestions 
deserve further investigation.
CONFLICT OF INTEREST
Th e authors declare no competing interests.
ACKNOWLEDGMENTS
Th is work was supported by Laboratorio de Biotec-
nologia Aplicada. L.B.A. Av. Don Julio Centeno, 
San Diego, Venezuela., Apartado 2001. We thank 
Girolamo Gonzalez-Barrera and Oriana Gonzalez-
Barrera for their cooperation.
REFERENCES
1. Huang CM. Comparative proteomic analysis of human whole saliva. Arch 
Oral Biol 2004;49:951-962.
2. Bardow A, Moe D, Nyvad B, Nauntofte B. The buffer capacity and buffer 
systems of human whole saliva measured without loss of CO2. Arch Oral 
Biol 2000;45:1-12.
3. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Im-
munol 2003;3:710-720.
4. Chen H, Xu Z, Peng L, et al. Recent advances in the research and develop-
ment of human defensins. Peptides 2006;27:931-940.
5. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in 
bacteria?. Nat Rev Microbiol 2005;3:238-250.
6. Lehrer RI, Barton A, Daher KA, et al. Interaction of human defensins 
with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 
1989;84:553-561.
7. Oppenheim FG, Xu T, McMillian FM, et al. Histatins, a novel family of his-
tidine-rich proteins in human parotid secretion. Isolation, characterization, 
primary structure, and fungistatic effects on Candida albicans. J Biol Chem 
1988;263:7472-7477.
8. Tanida T, Okamoto T, Okamoto A, et al. Decreased excretion of antimicro-
bial proteins and peptides in saliva of patients with oral candidiasis. J Oral 
Pathol Med 2003;32:586-594.
97
http://www.jhsci.ba  Girolamo Jose Barrera et al. Journal of Health Sciences 2013;3(2):88-97
9. Hollox EJ, Armour JA, Barber JC. Extensive normal copy number varia-
tion of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 
2003;73:591-600. 
10. Bradford MM. A rapid and sensitive method for the quantitation of micro-
gram quantities of protein utilizing the principle of protein-dye binding. Anal 
Biochem 1976;72:248-254.
11. Tao R, Jurevic RJ, Coulton KK, et al. Salivary antimicrobial peptide ex-
pression and dental caries experience in children. Antimicrob Agents Che-
mother 2005;49:3883-3888.
12. Barrera GJ, Sanchez G, Gonzalez JE. Trefoil factor 3 isolated from human 
breast milk downregulates cytokines (IL8 and IL6) and promotes human 
beta defensin (hBD2 and hBD4) expression in intestinal epithelial cells HT- 
29. Bosn J Basic Med Sci 2012;12(4):256-264.
13. Barrera GJ, Sanchez G, Gonzalez JE. Trefoil factor 3 (TFF3) expression is 
regulated by insulin and glucose. Journal of Health Sciences. 2013;3(1):1-
12
14. Dale BA, Tao R, Kimball JR, et al. Oral antimicrobial peptides and biological 
control of caries. BMC Oral Health 2006; 6 Suppl 1:S13.
15. Amerongen AV, Veerman EC. Saliva-the defender of the oral cavity. Oral 
Dis 2002;8:12-22.
16. Rudney JD, Hicckey KL, Ji Z. Cumulative correlations of lysozyme, lac-
toferrin, peroxidase, S-IgA, amylase, and total protein concentration with 
adherence of oral viridans streptococci to microplates coated with human 
saliva. J Dent Res 1999;78:759-768.
17.  Aframian DJ, Davidowitz T, Benoliel R. The distribution of oral mucosal pH 
values in healthy saliva secretors. Oral Dis 2006;12:420-423.
18.  Counotte GH, van't Klooster AT, van der Kuilen J, et al. An analysis of the 
buffer system in the rumen of dairy cattle. J Anim Sci 1979;49:1536-1544.
19.  Smith PM. Mechanisms of secretion by salivary glands. En: Edgar WM, 
Mullane DM, editors. Saliva and oral health. London: British Dental As-
sociation 1996. p.9-25.
20.  Lamanda A, Cheaib Z, Turgut MD, et al. Protein buffering in model systems 
and in whole human saliva. PLoS One 2007;2:e263.
21. Nagler RM, Klein I, Zarzhevsky N, et al. Characterization of the differenti-
ated antioxidant profi le of human saliva. Free Radic Biol Med 2002;32:268-
277.
22.  Pruitt KM, Kamau DN, Miller K, et al. Quantitative, standardized assays for 
determining the concentrations of bovine lactoperoxidase, human salivary 
peroxidase, and human myeloperoxidase. Anal Biochem 1990;191:278-
286.
23.  Tenovuo J, Larjava H. The protective effect of peroxidase and thiocya-
nate against hydrogen peroxide toxicity assessed by the uptake of [3H]-
thymidine by human gingival fi broblasts cultured in vitro. Arch Oral Biol 
1984;29:445-451.
24.  Yang D, Biragyn A, Hoover DM, et al. Multiple roles of antimicrobial de-
fensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. 
Annu Rev Immunol 2004;22:181-215.
25.  Mizukawa N, Sugiyama K, Ueno T, et al. Levels of human defensin-1, an 
antimicrobial peptide, in saliva of patients with oral infl ammation. Oral Surg 
Oral Med Oral Pathol Oral Radiol Endod 1999;87:539-543.
26. Dommisch H, Açil Y, Dunsche A, et al. Differential gene expression of hu-
man beta-defensins (hBD-1, -2, -3) in infl ammatory gingival diseases. Oral 
Microbiol Immunol 2005;20:186-190.
27. Hollox EJ, Armour JA, Barber JC. Extensive normal copy number varia-
tion of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 
2003;73:591-600. 
28. Samaranayake L. Saliva as a diagnostic fl uid. Int Dent J 2007;57:295-299.
